M4MM

Psyence Biomed Completes $2 Million Private Placement

LOS ANGELES- Psyence Biomedical Ltd. , a biotechnology firm specializing in psilocybin-based psychedelic medicines, has finalized a private placement, securing approximately $2 million in gross proceeds. The financing involved the issuance of 1,000,000 common shares ...

Constellation Brands: Analysts Maintain Ratings

LOS ANGELES- On Monday, Argus reaffirmed its Buy rating on shares of Constellation Brands (NYSE: STZ), maintaining a price target of $306.00. Argus notes the stock's value, currently trading at 18 times the firm's fiscal ...

Psyence Biomed Completes $2 Million Private Placement

LOS ANGELES- Psyence Biomedical Ltd. , a biotechnology firm specializing in psilocybin-based psychedelic medicines, has finalized a private placement, securing approximately $2 million in gross proceeds. The financing involved the issuance of 1,000,000 common shares ...

Subscribe To Our Newsletter